Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-514-3367800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$56.31 million
Profitability
Miscellaneous
Employees32
Next Earnings Date10/3/2019 (Estimated)
OptionableNot Optionable
Theratechnologies (TSE:TH) Frequently Asked Questions
What is Theratechnologies' stock symbol?
Theratechnologies trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TH."
How were Theratechnologies' earnings last quarter?
Theratechnologies Inc (TSE:TH) issued its earnings results on Thursday, July, 11th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business had revenue of $20.92 million for the quarter, compared to analyst estimates of $26 million. View Theratechnologies' Earnings History.
When is Theratechnologies' next earnings date?
What price target have analysts set for TH?
4 Wall Street analysts have issued 12 month price targets for Theratechnologies' shares. Their predictions range from C$7.00 to C$15.00. On average, they expect Theratechnologies' stock price to reach C$9.56 in the next twelve months. This suggests a possible upside of 68.1% from the stock's current price. View Analyst Price Targets for Theratechnologies.
What is the consensus analysts' recommendation for Theratechnologies?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Theratechnologies in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Theratechnologies.
Has Theratechnologies been receiving favorable news coverage?
Headlines about TH stock have trended somewhat positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Theratechnologies earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Theratechnologies.
Who are some of Theratechnologies' key competitors?
Some companies that are related to Theratechnologies include Polynovo (PNV), Concordia International (CXR), Clinuvel Pharmaceuticals (CUV), Mesoblast (MSB), Resverlogix (RVX), Kodiak Sciences (KOD), Neptune Wellness Solutions (NEPT), Starpharma (SPL), Biotest (BIO), BELLUS Health (BLU), Oxford BioMedica (OXB), ProMetic Life Sciences (PLI), Paradigm Biopharmaceuticals (PAR), Rafael (RFL) and CEL-SCI (CVM).
What other stocks do shareholders of Theratechnologies own?
Who are Theratechnologies' key executives?
Theratechnologies' management team includes the folowing people:
- Mr. Luc Tanguay, Pres, CEO & Non-Independent Director (Age 61)
- Mr. Philippe Dubuc MBA, Sr. VP & CFO (Age 52)
- Mr. Jocelyn Lafond, VP of Legal Affairs & Corp. Sec. (Age 51)
- Mr. Denis Boucher B.A., L.L.B., VP of Communications & Corp. Affairs (Age 53)
- Mr. Christian Marsolais, Sr. VP & Chief Medical Officer (Age 56)
How do I buy shares of Theratechnologies?
Shares of TH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Theratechnologies' stock price today?
One share of TH stock can currently be purchased for approximately C$5.69.
How big of a company is Theratechnologies?
What is Theratechnologies' official website?
How can I contact Theratechnologies?
Theratechnologies' mailing address is 2015 Peel St 5th Floor, MONTREAL, QC H3A 1T8, Canada. The company can be reached via phone at +1-514-3367800.
MarketBeat Community Rating for Theratechnologies (TSE TH)
MarketBeat's community ratings are surveys of what our community members think about Theratechnologies and other stocks. Vote "Outperform" if you believe TH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TH will underperform the S&P 500 over the long term. You may vote once every thirty days.
